Lab notes: Incyte gets two FDA approvals, Coriell gets $12.4M research grant, and more
This week's roundup on the region's life sciences industry includes one company securing two FDA approvals, a South Jersey institution receiving a $12 million research grant, and more. Here's the rundown:
Incyte Corp.
The Wilmington biotechnology company started the week receiving marketing clearance from the Food and Drug Administration for Opzelura, the company's topical cream for mild-to-moderate atopic dermatitis — a chronic skin disease that affects more than 21 million people in the Unit ed…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: John George Source Type: news
More News: Biotechnology | Dermatitis | Dermatology | Food and Drug Administration (FDA) | Grants | Health Management | Marketing | Pharmaceuticals | Skin